Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
45.64
-0.82 (-1.76%)
At close: Jul 21, 2025, 4:00 PM
45.60
-0.04 (-0.09%)
After-hours: Jul 21, 2025, 4:48 PM EDT

Company Description

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.

The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers.

It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform.

In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests.

The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Guardant Health, Inc.
Guardant Health logo
CountryUnited States
Founded2011
IPO DateOct 4, 2018
IndustryDiagnostics & Research
SectorHealthcare
Employees2,021
CEODr. Helmy Eltoukhy Ph.D.

Contact Details

Address:
3100 Hanover Street
Palo Alto, California 94304
United States
Phone855 698 8887
Websiteguardanthealth.com

Stock Details

Ticker SymbolGH
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001576280
CUSIP Number40131M109
ISIN NumberUS40131M1099
Employer ID45-4139254
SIC Code8071

Key Executives

NamePosition
Dr. AmirAli Talasaz Ph.D.Co-Chief Executive Officer and Director
Dr. Helmy Eltoukhy Ph.D.Co-Founder, Co-Chief Executive Officer and Chairman
Michael BellChief Financial Officer
Darya ChudovaChief Technology Officer
John G. Saia J.D.Chief Legal Officer and Corporate Secretary
Terilyn Juarez MonroeChief People Officer
Andy AmentSenior Vice President of Operations
Kumud KaliaChief Information Officer
Zarak KhurshidVice President of Investor Relations
Gulshan Shaver J.D.Senior Vice President of Legal Affairs and Chief Compliance Officer

Latest SEC Filings

DateTypeTitle
Jul 17, 2025144Filing
Jul 17, 2025144Filing
Jun 20, 20258-KCurrent Report
Jun 18, 2025144Filing
Jun 18, 2025144Filing
Jun 17, 2025144Filing
Jun 16, 2025144Filing
Jun 13, 2025144Filing
Jun 3, 2025144Filing
Jun 2, 2025144Filing